Contact your GP, specialist, or clinical trial team promptly if you experience: A spreading rash , hives (urticaria), or widespread skin redness that develops after starting treatment Swelling of the face, lips, tongue, or throat , which may indicate angioedema a potentially serious allergic reaction requiring urgent assessment Difficulty breathing or swallowing alongside skin changes call 999 immediately , as this could indicate anaphylaxis Signs of infection at an injection site , including increasing warmth, pus, significant swelling, or fever Persistent or worsening skin symptoms that do not improve with basic self-care measures after one to two weeks Unexplained bruising or bleeding beyond what would be expected from a subcutaneous injection If you are unsure whether your symptoms require urgent attention, NHS 111 can provide guidance
Key Question: As the GLP-1 consumer becomes mainstream, how should brands and marketers adapt their strategies
Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: An emulated trial study
Karnitin ve CLA rnleri farkl isimlere sahip olsa da amalar ayn yndedir
[] Forecasts indicate that by 2040, the prevalence will increase to 2.4 million cases and 712,000 fatalities as a result of demographic aging and expansion
Research into the health benefits of dark-roast coffee is mixed: Antioxidant levels